Vizsgálati helyszín
Klinische Forschung Berlin-Mitte GmbH
Berlin, 10117, NémetországMég nincs intézményhez kötve
- 13futó vizsgálat
- 11lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 24 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis16 vizsgálat
- 2. fázis4 vizsgálat
- 4. fázis3 vizsgálat
- 1. fázis1 vizsgálat
- Állapot
- Lezárult11 vizsgálat
- Fut, nem toboroz7 vizsgálat
- Toboroz5 vizsgálat
- Még nem toboroz1 vizsgálat
- Fő szponzor
- Dr. Willmar Schwabe GmbH & Co. KG2 vizsgálat
- ModernaTX, Inc.2 vizsgálat
- Pfizer2 vizsgálat
- Anthos Therapeutics, Inc.1 vizsgálat
- AstraZeneca1 vizsgálat
- és még 16
Futó vizsgálatok
Toboroz
A Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
2025-524616-11-00· 3. fázis· AstraZeneca AB· Forrás
Még nem toboroz
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CD388, a Novel Long-Acting Antiviral Conjugate, for the Prevention of Influenza in Adults and Adolescents at Higher Risk of Developing Influenza Complications
2026-527531-33-00· 3. fázis· Cidara Therapeutics Inc.· Forrás
Toboroz
A study on the efficacy of a vaccine against influenza in adults ≥65 years of age
2026-526682-14-00· 3. fázis· GlaxoSmithKline Biologicals· Forrás
Toboroz
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
NCT07784725· 3. fázis· AstraZeneca· Forrás
Fut, nem toboroz
A prospective, multicentre, randomised, double-dummy, double-blind, placebo-controlled 3-way Phase III study to investigate the efficacy and safety of two dexamfetamine sulfate formulations in adults with ADHD - DEXINA -
2022-502903-31-00· 3. fázis· Medice Arzneimittel Puetter GmbH & Co. KG· Forrás
Fut, nem toboroz
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
NCT07400653· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
NCT07311850· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
Silexan® in mild to moderate major depressive disorder
2025-521744-37-00· 3. fázis· Dr. Willmar Schwabe GmbH & Co. KG· Forrás
Fut, nem toboroz
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
NCT06557772· 2. fázis· Sanofi· Forrás
Fut, nem toboroz
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
NCT06154837· 1. fázis· GlaxoSmithKline· Forrás
Toboroz
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200· 3. fázis· Anthos Therapeutics, Inc.· Forrás
Toboroz
Controlled clinical trial to investigate the efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhoea-dominant irritable bowel syndrome (IBS-D) and patients with mixed-type irritable bowel syndrome (IBS-M)
2024-514892-16-00· 4. fázis· REPHA GmbH Biologische Arzneimittel· Forrás
Toboroz
Randomized, double-blind, placebo-controlled, multi-centre trial to evaluate the efficacy, safety and tolerability of oral treatment with living bacteria of E. coli DSM 17252 (Symbioflor®2) in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D)
2024-512104-19-00· 4. fázis· SymbioPharm GmbH· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis
NCT06867094· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás
Lezárult
A trial to find the effect of Ginkgo biloba extract EGb 761® and how safe it is in participants with cognitive impairment associated with post COVID-19 syndrome
2024-517199-39-00· 2. fázis· Dr. Willmar Schwabe GmbH & Co. KG· Forrás
Lezárult
A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia
2024-511057-22-00· 3. fázis· Janssen Cilag International· Forrás
Lezárult
Long-term Study to Assess the Safety and Effectiveness of NMRA-335140 in Participants with Major Depressive Disorder
NCT06029439· 3. fázis· Neumora Therapeutics Inc.· Forrás
Lezárult
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
NCT06602024· 3. fázis· ModernaTX, Inc.· Forrás
Lezárult
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
NCT06058039· 3. fázis· Neumora Therapeutics, Inc.· Forrás
Lezárult
The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older
NCT06015282· 3. fázis· Seqirus· Forrás
Lezárult
The Celljuvant study, A phase 3 Immunogenicity and Safety Study of aQIVc HD Vaccine in Adults aged 50 years and older.
2023-503763-42-00· 3. fázis· Seqirus UK Limited· Forrás
Lezárult
Efficacy and Tolerability of Tasipimidine in Sleepless Patients
NCT06956495· 2. fázis· Orion Corporation, Orion Pharma· Forrás
Lezárult
The RADIAL study: A clinical trial to learn more about the benefits and the acceptability of trials that include technology to centre the trial around the participant, known as decentralised, and hybrid clinical trials compared to standard clinical trials that take place in hospitals or in research centres, in patients with type 2 diabetes mellitus treated with Toujeo®, a drug to help manage blood sugar levels.
2022-500449-26-00· 4. fázis· University Medical Center Utrecht· Forrás
Lezárult
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
NCT05566639· 3. fázis· ModernaTX, Inc.· Forrás
Hibát jelzek